Construction of immune cell infiltration score model to assess prognostic ability of tumor immune environment in lung adenocarcinoma

被引:0
|
作者
Tian, Jiahui [1 ,2 ]
Fu, Chunyan [1 ,2 ]
Peng, Qian [2 ]
Yang, Jialu [1 ]
Fan, Xiaoxiao [1 ]
Zeng, Xuan [2 ]
Qing, Weiguo [1 ]
Wu, Yi [1 ,2 ]
机构
[1] Hunan Normal Univ, Affiliated Hosp 1, Dept Lab, Changsha 410005, Hunan, Peoples R China
[2] Hunan Normal Univ, Dept Med, Changsha 410005, Hunan, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2023年 / 15卷 / 03期
关键词
Lung adenocarcinoma; immune cell infiltration; tumor microenvironment; immunotherapy; prognosis evaluation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The immune cell infiltration (ICI) in the tumor microenvironment (TME) can provide a reference for prognosis after immunotherapy. We aim to establish an ICI scoring model and evaluate its predictive ability for the immunotherapy efficacy and the prognosis in lung adenocarcinoma (LUAD) patients. Methods: We developed and analyzed the landscape of infiltrative immune cells based on the CIBERSORT and ESTIMATE algorithms. Then, three clusters of LUAD patients were discerned from TCGA-LUAD and GSE11969 data. Furthermore, two gene clus-ters were classified based on the PCA. Results: LUAD patients with better prognoses tend to have higher immune checkpoint expression and immune/stromal scores. There is a correlation between TMB and ICI, and their relation-ship deserves further exploration. Moreover, the early-stage and male patients with high ICI scores have more pro-longed survival. Conclusions: The feasibility of the ICI score model in evaluating prognosis after immune checkpoint therapy for LUAD patients was verified, specifically reflected in the screening of sensitive immune checkpoints as a treatment reference. The scoring system can accurately predict the overall survival of LUAD patients, which has clinical value to monitor disease and evaluate prognosis.
引用
收藏
页码:1730 / +
页数:17
相关论文
共 50 条
  • [21] ADAM12 as a Clinical Prognostic Indicator Associated with Tumor Immune Infiltration in Lung Adenocarcinoma
    Pan, Junfan
    Huang, Zhidong
    Zhang, Yuan
    Xu, Yiquan
    DNA AND CELL BIOLOGY, 2022, 41 (04) : 410 - 423
  • [22] Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma
    Yin, Xiang-Qian
    Yin, Xue-Hui
    Yu, Ya-Qin
    Xu, Lang
    Zhang, Mao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] DLX1 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression in lung adenocarcinoma
    Du, Yu
    Li, Heng
    Wang, Yan
    He, Yunyan
    Li, Gaofeng
    PEERJ, 2024, 12
  • [24] MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
    Hu, Yangyang
    Liu, Yue
    Ma, Chenchao
    Ai, Kaixing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [25] Prognostic Value of GIMAP4 and Its Role in Promoting Immune Cell Infiltration into Tumor Microenvironment of Lung Adenocarcinoma
    Chen, Siyuan
    Tian, Dong
    Petersen, Lauren
    Cao, Shuchang
    Quinn, Zachary
    Kan, Junyan
    Zheng, Mingfeng
    Mao, Wenjun
    Wan, Yuan
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [26] Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences
    Fan, Tao
    Li, Chunxiang
    He, Jie
    BIOLOGY OF SEX DIFFERENCES, 2021, 12 (01)
  • [27] Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences
    Tao Fan
    Chunxiang Li
    Jie He
    Biology of Sex Differences, 12
  • [28] SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
    Xiuao Zhang
    Zhengcun Wu
    Kaili Ma
    BMC Cancer, 22
  • [29] Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
    Xia, Zhi
    Rong, Xueyao
    Dai, Ziyu
    Zhou, Dongbo
    FRONTIERS IN GENETICS, 2022, 13
  • [30] Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma
    Qi, Xiaoguang
    Qi, Chunyan
    Qin, Boyu
    Kang, Xindan
    Hu, Yi
    Han, Weidong
    FRONTIERS IN ONCOLOGY, 2020, 10